Baxdrostat Slashes BP in Resistant Hypertension: BrigHTN
The novel agent lowers aldosterone activity without the off-target inhibition of cortisol synthesis that has thwarted previous drug candidates, the researchers say.
Source: medscape.com
Masonw Freeman News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Masonw Freeman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Masonw Freeman Today - Breaking & Trending Today
Baxdrostat Studied in Treatment-Resistant Hypertension
Patients with treatment-resistant hypertension who receive baxdrostat vs placebo have dose-dependent reductions in systolic blood pressure at 12 weeks.
Source: empr.com
CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
22.03.2022 - BrigHtn Phase 2 study with CIN-107 for Resistant Hypertension Enrollment Complete with Topline Results Expected in 2H 2022 Topline Data from HALO Phase 2 study with CIN-107 for Uncontrolled Hypertension Expected in 2H 2022 Mason Freeman, M.D. ...
Source: wallstreet-online.de
BioSpace Mover & Shakers, Oct. 22
BioSpace Mover & Shakers, Oct. 22 - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
BioSpace Mover & Shakers, Oct. 22
BioSpace Mover & Shakers, Oct. 22 - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com